Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

654 ARTÍCULOS , VIENDO DEL 301 AL 315

Medications used to treat tremors

Frei K, Truong DD.

J Neurol Sci. 2022 Apr 15;435:120194. doi: 10.1016/j.jns.2022.120194. Epub 2022 Feb 19.

Problems and controversies in tremor classification

Louis ED, Bain PG.

J Neurol Sci. 2022 Apr 15;435:120204. doi: 10.1016/j.jns.2022.120204. Epub 2022 Feb 19.

The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease

Henderson MX, Henrich MT, Geibl FF, Oertel WH, Brundin P, Surmeier DJ.

Neurobiol Dis. 2022 Jun 15;168:105687. doi: 10.1016/j.nbd.2022.105687. Epub 2022 Mar 10.

α-Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives

Alzghool OM, van Dongen G, van de Giessen E, Schoonmade L, Beaino W.

Mov Disord. 2022 May;37(5):936-948. doi: 10.1002/mds.28984. Epub 2022 Mar 15.

Remote measurement and home monitoring of tremor

Mari Z, Haubenberger D.

J Neurol Sci. 2022 Apr 15;435:120201. doi: 10.1016/j.jns.2022.120201. Epub 2022 Feb 22.

Botulinum Toxin for Essential Tremor and Hands Tremor in the Neurological Diseases: A Meta-Analysis of Randomized Controlled Trials

Liao YH, Hong CT, Huang TW.

Toxins (Basel). 2022 Mar 10;14(3):203. doi: 10.3390/toxins14030203.

Personality Changes After Subthalamic Nucleus Stimulation in Parkinson's Disease

Brezovar S, Pažek L, Kavčič M, Georgiev D, Trošt M, Flisar D.

J Parkinsons Dis. 2022;12(4):1231-1240. doi: 10.3233/JPD-212879.

Distribution of α-Synuclein Aggregation in the Peripheral Tissues

Li YY, Zhou TT, Zhang Y, Chen NH, Yuan YH.

Neurochem Res. 2022 Dec;47(12):3627-3634. doi: 10.1007/s11064-022-03586-0. Epub 2022 Mar 28.

Kinesigenic dyskinesias after ENT surgery misdiagnosed as focal epilepsy

Trapp SD, Noachtar S, Kaufmann E.

BMJ Case Rep. 2022 Mar 29;15(3):e247760. doi: 10.1136/bcr-2021-247760.

Neuropsychological Functioning in Primary Dystonia: Updated and Expanded Multidomain Meta-Analysis

Aita SL, Del Bene VA, Marotta DA, Pizer JH, Hawley NA, Niccolai L, Walker HC, Gerstenecker A, Martin RC, Clay OJ, Crowe M, Triebel KL, Hill BD.

Mov Disord. 2022 Jul;37(7):1483-1494. doi: 10.1002/mds.29022. Epub 2022 Apr 6.

Small and Large Magnetic Resonance Imaging-Visible Perivascular Spaces in the Basal Ganglia of Parkinson's Disease Patients

Ramirez J, Berberian SA, Breen DP, Gao F, Ozzoude M, Adamo S, Scott CJM, Berezuk C, Yhap V, Mestre TA, Marras C, Tartaglia MC, Grimes D, Jog M, Kwan D, Tan B, Binns MA, Arnott SR, Bartha R, Symons S, Masellis M, Black SE, Lang AE; ONDRI Investigators.

Mov Disord. 2022 Jun;37(6):1304-1309. doi: 10.1002/mds.29010. Epub 2022 Apr 11.

Respiratory Abnormalities in Parkinson's Disease: What Do We Know from Studies in Humans and Animal Models?

Kaczyńska K, Orłowska ME, Andrzejewski K.

Int J Mol Sci. 2022 Mar 23;23(7):3499. doi: 10.3390/ijms23073499.

A Randomized First-in-Human Study With UB-312, a UBITh® α-Synuclein Peptide Vaccine

Yu HJ, Thijssen E, van Brummelen E, van der Plas JL, Radanovic I, Moerland M, Hsieh E, Groeneveld GJ, Dodart JC.

Mov Disord. 2022 Jul;37(7):1416-1424. doi: 10.1002/mds.29016. Epub 2022 Apr 15.

Parkinsonism in multiple sclerosis patients: A prospective observational study

Sarin S, Wang A, Elkasaby M, Abboud H.

Mult Scler Relat Disord. 2022 Jun;62:103796. doi: 10.1016/j.msard.2022.103796. Epub 2022 Apr 10.

Sodium-glucose cotransporter 2 inhibitors and neurological disorders: a scoping review

Tharmaraja T, Ho JSY, Sia CH, Lim NA, Chong YF, Lim AYL, Rathakrishnan RR, Yeo LLL, Sharma VK, Tan BYQ.

Ther Adv Chronic Dis. 2022 Apr 11;13:20406223221086996. doi: 10.1177/20406223221086996. eCollection 2022.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias